DOJ to review alleged Biden autopen pardons, raising concerns over cognitive decline and unauthorized executive actions.
Gayle King, co-host of CBS Mornings, is expected to leave her role when her contract expires in May 2026, potentially moving to a different or behind-the-scenes position.
Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
DOJ to review alleged Biden autopen pardons, raising concerns over cognitive decline and unauthorized executive actions.
Gayle King, co-host of CBS Mornings, is expected to leave her role when her contract expires in May 2026, potentially moving to a different or behind-the-scenes position.
Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.